Prescription Pharmacy | Online Pharmacy Prescription | Internet Pharmacies Prescription
www.onlinepharmacyrx.org
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Levonorgestrel - Alesse, Plan B, Tegretol
Generic Alesse
Levonorgestrel bp + ethinylestradiol bp 0.10mg + 0.02/0.15mg + 0.03/0.25mg + 0.05mg
Generic Alesse is used for preventing pregnancy.
$1.04
Buy now!
Generic Plan B
Generic Plan B is used for preventing pregnancy after unprotected sexual intercourse or suspected birth control failure.
$5.00
Buy now!
Generic Tegretol
Controlling certain types of seizures and relieving pain in patients with nerve pain in the face, jaw, tongue, or throat.
$0.61
Buy now!
Choose Your language:
- Testimonials
-
Yes I received the order.. It was a good deal . 60 pills for \$119. Is this offer still in place?? - Thanks!
Read more »
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Birth control patch and ring may raise blood clot risk - Fox News
- Zee NewsBirth control patch and ring may raise blood clot riskFox NewsIn the study examining women over a 10-year period, a blood clot was twice as likely to appear in those who used a vaginal ring as in those who took birth control pills containing levonorgestrel, a synthetic form of the female hormone progesterone
- New Phase III Data Show Agile Therapeutics' Low-Dose Patch Is Comparable to ... - MarketWatch (press release)
- New Phase III Data Show Agile Therapeutics' Low-Dose Patch Is Comparable to
- Studies Show Conflicting Findings on Risk of VTE with NuvaRing - InjuryBoard.com
- Studies Show Conflicting Findings on Risk of VTE with NuvaRingInjuryBoard
- Progestin-Based IUD Not Linked to Weight Gain - MedPage Today
- Progestin-Based IUD Not Linked to Weight GainMedPage TodayA small, retrospective study found no difference in weight at 2 years after insertion of a levonorgestrel-eluting IUD versus a copper IUD
- ACOG: Intrauterine Device Insertion Linked to Weight Loss - Doctors Lounge
- ACOG: Intrauterine Device Insertion Linked to Weight LossDoctors LoungeWomen who undergo postpartum or interval insertion of Levonorgestrel-releasing Intrauterine System or Copper T 380A intrauterine devices experience weight loss in the two years following insertion, according to a study presented at the annual clinical
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
